The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A live, attenuated recombinant West Nile virus vaccine
Open accessAbstract
West Nile (WN) virus is an important cause of febrile exanthem and encephalitis. Since it invaded the U.S. in 1999, >19,000 human cases have been reported. The threat of continued epidemics has spurred efforts to develop vaccines. ChimeriVax-WN02 is a live, attenuated recombinant vaccine constructed from an infectious clone of yellow fever (YF) 17D virus in which the premembrane and envelope genes of 17D have been replaced by the corresponding genes of WN virus. Preclinical tests in monkeys defined sites of vaccine virus replication in vivo . ChimeriVax-WN02 and YF 17D had similar biodistribution but different multiplication kinetics. Prominent sites of replication were skin and lymphoid tissues, generally sparing vital organs. Viruses were cleared from blood by day 7 and from tissues around day 14. In a clinical study, healthy adults were inoculated with 5.0 log 10 plaque-forming units (PFU) ( n = 30) or 3.0 log 10 PFU ( n = 15) of ChimeriVax-WN02, commercial YF vaccine (YF-VAX, n = 5), or placebo ( n = 30). The incidence of adverse events in subjects receiving the vaccine was similar to that in the placebo group. Transient viremia was detected in 42 of 45 (93%) of ChimeriVax-WN02 subjects, and four of five (80%) of YF-VAX subjects. All subjects developed neutralizing antibodies to WN or YF, respectively, and the majority developed specific T cell responses. ChimeriVax-WN02 rapidly elicits strong immune responses after a single dose, and is a promising candidate warranting further evaluation for prevention of WN disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864
Cited by
Current Status of Veterinary Vaccines
Meeusen, E. N. T., Walker, J., Peters, A., Pastoret, P.-P., & Jungersen, G. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-07 · Cited by 517
Monath, T. P. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.4.553 · Cited by 467
Self-citationWest Nile virus infection and immunity
Suthar, M. S., Diamond, M. S., & Gale Jr, M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2950 · Cited by 430
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Akondy, R. S., Monson, N. D., Miller, J. D., Edupuganti, S., Teuwen, D., Wu, H., Quyyumi, F., Garg, S., Altman, J. D., Del Rio, C., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803903 · Cited by 343
Guy, B., Guirakhoo, F., Barban, V., Higgs, S., Monath, T. P., & Lang, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.09.098 · Cited by 291
Self-citation
Metadata
- Authors
- Monath, T. P., Liu, J., Kanesa-Thasan, N., Myers, G. A., Nichols, R., Deary, A., McCarthy, K., Johnson, C., Ermak, T., Shin, S., Arroyo, J., Guirakhoo, F., Kennedy, J. S., Ennis, F. A., Green, S., & Bedford, P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-04-25
- Volume
- 103
- Issue
- 17
- Pages
- 6694-6699
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2106056357
- Cited by
- 231
- References
- 1
- FWCI
- 23.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A live, attenuated recombinant West Nile virus vaccine. https://app.cochat.ai/papers/10.1073/pnas.0601932103
- The paper
- Monath, T. P., Liu, J., Kanesa-Thasan, N., Myers, G. A., Nichols, R., Deary, A., McCarthy, K., Johnson, C., Ermak, T., Shin, S., Arroyo, J., Guirakhoo, F., Kennedy, J. S., Ennis, F. A., Green, S., & Bedford, P. (2006). A live, attenuated recombinant West Nile virus vaccine. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0601932103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.